| Stage | ACEL | % of rev | LYV | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $364M | 100.00% | $7.7B | 100.00% | LYV ×21.09 |
| Gross profit | $363M | 99.86% | $1.9B | 25.34% | ACEL +74.5pp |
| Operating income | $29M | 7.92% | $522M | 6.81% | ACEL +1.1pp |
| Pre-tax income | $26M | 7.10% | $519M | 6.76% | ACEL +0.3pp |
| Net income | $21M | 5.67% | $403M | 5.25% | ACEL +0.4pp |
| Stage | ACEL | LYV | Gap · A − B |
|---|---|---|---|
| Revenue | $364M100.00% | $7.7B100.00% | LYV ×21.09 |
| Gross profit | 99.86%$363M | 25.34%$1.9B | ACEL +74.5pp |
| Operating income | 7.92%$29M | 6.81%$522M | ACEL +1.1pp |
| Pre-tax income | 7.10%$26M | 6.76%$519M | ACEL +0.3pp |
| Net income |
| 5.67%$21M |
| 5.25%$403M |
| ACEL +0.4pp |
No disclosed counterparties: LYV.
None